Spero Therapeutics (SPRO) PT Lowered to $20 at Oppenheimer

March 12, 2021 8:54 AM EST Send to a Friend

Oppenheimer analyst Kevin DeGeeter lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Spero Therapeutics (SPRO) PT Lowered to $20 at Oppenheimer

Member Login

Free News Feed